Grant: Engage Grants Program
University of Calgary
$25,000.00
Microfluidic bioreactors for perfusion of 3D bioprinted tissues
FY 2018-19
Summary
3D printing has changed the ways of practice in many applications including biomedical and tissue engineering. In particular, 3D printing is now used for the bioprinting of vascular tissues and drug delivery. The existing 3D bioprinters suffer from a mimetic delivery system, known as perfusion system, to provide nutrients to cell-laden bioprinted hydrogels. In partnership with one of the pioneering companies in 3D bioprinting, this research aims at developing a microfluidic based perfusion system for the delivery of nutrients, oxygen and drugs to 3D tissues. These perfusion systems will benefit 3D printing industry in drastically expanding the capability for long-term cell culture, disease modeling and drug testing on vascular tissues. The industry partner for this project, Aspect Biosystems, is a leading tech company providing solutions for bioprinting. These perfusion systems will benefit Aspect Biosystems in drastically expanding their capability for long-term cell culture, disease modeling and drug testing on vascular tissues. The advancement in the perfusion system will open up new markets and will improve company competitiveness.*
Program
Engage Grants Program
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
535912-2018
Name nom
Hejazi, SeyedHossein
Department département
Chemical and Petroleum Engineering
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
2202
Research subject group en
Fluid mechanics
Research subject group fr
Mécanique des fluides
Research subject en
Multi-phase systems
Research subject fr
Systèmes polyphasiques
Partie
1
Nb partie
1
Application title
Microfluidic bioreactors for perfusion of 3D bioprinted tissues
Keyword
NSERC
Application summary
3D printing has changed the ways of practice in many applications including biomedical and tissue engineering. In particular, 3D printing is now used for the bioprinting of vascular tissues and drug delivery. The existing 3D bioprinters suffer from a mimetic delivery system, known as perfusion system, to provide nutrients to cell-laden bioprinted hydrogels. In partnership with one of the pioneering companies in 3D bioprinting, this research aims at developing a microfluidic based perfusion system for the delivery of nutrients, oxygen and drugs to 3D tissues. These perfusion systems will benefit 3D printing industry in drastically expanding the capability for long-term cell culture, disease modeling and drug testing on vascular tissues. The industry partner for this project, Aspect Biosystems, is a leading tech company providing solutions for bioprinting. These perfusion systems will benefit Aspect Biosystems in drastically expanding their capability for long-term cell culture, disease modeling and drug testing on vascular tissues. The advancement in the perfusion system will open up new markets and will improve company competitiveness.*